A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trials
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.atherosclerosis.2026.120742
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0021915026001085
其他信息:
出版社: Elsevier BV
作者: Patrick Nolain; Magnus Fugger; Bibi Toft Hellinghus; Ingo Hilgendorf; Jesper Falkesgaard Højen; Peter Libby; Giovanna Liuzzo; Christian M. Matter; Katherine R. Tuttle; Paul M Ridker

